Re-start of anticoagulant therapy for acute phase of intracerebral hemorrhage patients -multi center observational study-

Re-start of anticoagulant therapy for acute phase of intracerebral hemorrhage patients -multi center observational study- - Re-start of anti-coagulant therapy for acute phase of intracerebral hemorrhage

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003413

Enrollment

Registered

2010-04-20

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral hemorrhage

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The intracerebral hemorrhage who received warfarin therapy and admitt within 3 days after onset

Exclusion criteria

Exclusion criteria: intracerebral hemorrhage due to brain tumor, anomaly of cerebral vessel, unruptured aneurysm, trauma Coma

Design outcomes

Primary

Measure	Time frame
Outcome (at discharge and 3 months after onset)	—

Countries

Japan

Outcome results